These effects increase skeletal muscle insulin resistance and associated with high expression of circulating cytokines as TNF-α, TNF-β and IL-6, promoted by abdominal obesity, increasing muscle catabolic activity [40]. The gene discussed is TNF; the disease is Insulin resistance.